NDC 17156-024

Myoview

Tetrofosmin

Myoview is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Medi-physics Inc. Dba Ge Healthcare. The primary component is Tetrofosmin.

Product ID17156-024_469ca3ab-5d9c-4af2-98b8-7b7965562bb8
NDC17156-024
Product TypeHuman Prescription Drug
Proprietary NameMyoview
Generic NameTetrofosmin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date1996-02-09
Marketing CategoryNDA /
Application NumberNDA020372
Labeler NameMedi-Physics Inc. dba GE Healthcare
Substance NameTETROFOSMIN
Active Ingredient Strength0 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 17156-024-05

5 VIAL in 1 KIT (17156-024-05) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Marketing Start Date2022-03-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17156-024-05 [17156002405]

Myoview INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA020372
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-08-08
Marketing End Date2017-05-31

Drug Details

NDC Crossover Matching brand name "Myoview" or generic name "Tetrofosmin"

NDCBrand NameGeneric Name
17156-024MyoviewTetrofosmin
17156-026MyoviewTetrofosmin
51808-223TetrofosminTetrofosmin

Trademark Results [Myoview]

Mark Image

Registration | Serial
Company
Trademark
Application Date
MYOVIEW
MYOVIEW
75011718 2072692 Live/Registered
GE HEALTHCARE LIMITED
1995-10-30
MYOVIEW
MYOVIEW
74214130 not registered Dead/Abandoned
AMERSHAM INTERNATIONAL PLC
1991-10-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.